BARCLAYS PLC

Position in MDXG — Mimedx Group, Inc.

CIK 312069 LONDON, X0

Position in MDXG

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$740,462

-$1,802,518 QoQ

Shares Held

187,459

-50.1% QoQ

Ownership

0.126%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2021

14 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

BARCLAYS PLC holds $1,494,072,071 across 362 Biotechnology names. MDXG ranks #120 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	663,263	$296,173,457
2	REGN	Regeneron Pharmaceuticals, Inc.	313,093	$241,908,173
3	ALNY	Alnylam Pharmaceuticals, Inc.	220,623	$72,997,531
4	MRNA	Moderna, Inc.	932,269	$47,359,264
5	INSM	INSMED Inc	275,731	$45,087,531
6	ROIV	Roivant Sciences Ltd.	1,415,848	$39,218,988
7	RVMD	Revolution Medicines, Inc.	383,179	$37,264,156
8	TERN	Terns Pharmaceuticals, Inc.	669,601	$35,301,364

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$740,462	187,459	-50.1%	Shares	Defined	2026-05-15
2025-12-31	$2,542,980	375,625	+7.6%	Shares	Sole	2026-02-13
2025-09-30	$2,436,424	349,058	-14.4%	Shares	Sole	2026-03-31
2025-06-30	$2,491,174	407,721	+86.0%	Shares	Sole	2026-02-27
2025-03-31	$1,665,555	219,152	-12.8%	Shares	Sole	2026-03-17
2024-12-31	$2,417,996	251,351	-4.2%	Shares	Sole	2026-03-19
2024-09-30	$1,551,073	262,449	+163.9%	Shares	Sole	2026-03-31
2024-06-30	$689,146	99,444	-29.1%	Shares	Sole	2026-03-23
2024-03-31	$1,080,025	140,263	-49.1%	Shares	Sole	2026-03-24
2023-12-31	$2,418,046	275,718	+372491.9%	Shares	Sole	2026-03-24
2023-09-30	$539	74	-66.4%	Shares	Sole	2026-03-26
2023-03-31	$750	220	-71.2%	Shares	Sole	2026-03-30
2022-06-30	$2,647	763	-92.4%	Shares	Sole	2022-08-12
2021-09-30	$60,600	10,000	—	Shares	Defined	2021-11-09
No filing history on record for this holder in this stock.